Acompanhe as Notícias da Recifes

Stock markets fall as analysts price in two quarter-point UK rate rises by the end of the yearBusiness live – latest updatesOil and gas prices have jumped and expectations of interest rate rises in Europe have increased after the US carried out a third night of military strikes against Iran.Brent crude, the international benchmark for oil prices, rose by as much as 4.6% to $87.08 a barrel on Tuesday, its highest level in just over a month. Continue reading...

Brent crude rises over $85 a barrel after US carries out third night of strikes against IranGood morning, and welcome to our rolling coverage of business, the financial markets and the world economy.Oil prices rose more than 2% after the conflict in the Middle East worsened, with the US carrying out a third consecutive night of strikes against Iran. Two tankers came under fire in the strait of Hormuz.Stasis has taken over markets as investors wait for the latest twist in the Iran confl

Brent crude jumps 3.4% and European markets drop, with airlines including Ryanair among hardest hitBusiness live – latest updatesOil prices jumped and stocks fell after the US launched a fresh wave of attacks against Iran amid an escalating standoff over the strait or Hormuz.Brent crude, the international benchmark for oil prices, rose 3.4% to $78.59 a barrel on the renewed hostilities in the Middle East. It had been trading at $72.48 before the outbreak of the war in February, and hit

Proposed legal settlement over 2022 oil spill would resolve allegations that South Bow violated clean water lawsA proposed legal settlement with the US government would require the Keystone pipeline system’s operator to pay a $26.9m civil penalty over a large oil spill in Kansas in December 2022 and spend about $40m more to prevent future accidents.The agreement would resolve allegations from the US Environmental Protection Agency (EPA) and Kansas that South Bow, based in Canada, viola

Brent crude dips slightly below $78 a barrel; most Asian stock markets bounce backBritain’s second-biggest drugmaker GSK has also taken a hit from recent drug failures.The Californian biotech Alector has said that GSK has ended their neuroscience collaboration covering ​two experimental antibody drugs, after both drug candidates suffered setbacks in clinical trials.The CARDIO-TTRansform trial was designed to examine the role of Wainua, a gene silencer treatment, on top of today’s stand